PER 1.18% 8.4¢ percheron therapeutics limited

Ann: Positive PDCO opinion and A$20m Placement, page-69

  1. 4,683 Posts.
    lightbulb Created with Sketch. 1086
    RC,

    The market is a forward looking instrument.

    The market will value the unique opportunity here...way ahead of revenue!

    ATL1102 will be a First in Class + Best in Class drug...protected by ODD for 7 - 10 years.

    We are talking $4B per year market just for non-ambulant boys (EU/US).

    Say they attain only 50% of the market - that is still $2B per year revenue.

    Currently we are sitting at sub $150m market cap.

    So...soon we start the value accretion in line with FA progress.

    The only way is up...baby...for you and me!
    .
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.4¢
Change
-0.001(1.18%)
Mkt cap ! $75.72M
Open High Low Value Volume
8.4¢ 8.4¢ 8.3¢ $3.097K 37.23K

Buyers (Bids)

No. Vol. Price($)
1 29206 8.3¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 118557 1
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.